Although cost-related asthma treatment nonadherence has declined in the US, nearly 1 in 6 patients are still nonadherent due to cost concerns.

Some healthcare professionals are unaware of the link between the menopause and the potentially-deadly condition, which ...

A simple, noninvasive nasal swab identified a predominance of T2-low asthma subtypes in racial and ethnic minority pediatric ...

A set of chameleon-like immune cells could be contributing to severe asthma in some patients.Intermediate group 2 i ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

How can a long-standing cough that does not produce phlegm, and stops as soon as you fall asleep, be cured by watching a ...

“Preventing unnecessary exposure to air pollution and consistently wearing masks in high-risk environments can significantly ...

Two-thirds of toddlers with peanut allergy who used the VIASKIN Peanut patch from DBV Technologies completed an oral food ...

A study reveals that shape-shifting immune cells, intermediate ILC2s, may contribute to severe asthma and resistance to ...